Christine Marie Utter

Christine Marie Utter, listed as finance chief, appears in our data through filings on PTC Therapeutics, Inc. shares, published by SEC (Form 4). In total, 126 filings cover trades dated from 4 January 2018 to 18 February 2026.

Sales make up the whole of the open-market record (79 sales, €8.4M). Outside the open market, there are 8 share grants and 39 option exercises. In 2026 alone, the filings show no purchases and 4 sales.

On 20 February 2026 came the latest disclosure, an open-market sale for €146k in PTC Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.